David T. Kim
Farallon Capital Management Llc
Assets Managed
$17.543B
Holdings
172
Last Quarter
2026 - Q1
Filed Date
1mo ago
Growth Rate
-17.22%(2Q avg: -15.23%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Farallon Capital Management Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 172 positions.
Assets under management
The assets under management (AUM) of Farallon Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 17.543B in assets, with a quarterly growth rate of -17.22% and a 2-quarter average growth rate of -15.23%. The portfolio is managed by David T. Kim, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
ur-4⤦ State Str Spdr S&p 500 Etf T
| 8.53% | $1.496B↓ Put 2.3M shares@ $650.34 avg price | New Position |
RVMD Revolution Medicines Inc
| 7.55% | $1.323B 13.605M shares@ $97.25 avg price | Decreased -6.7% |
AMZN Amazon.com Inc
| 5.01% | $878.565M 4.218M shares@ $208.27 avg price | Decreased -6.25% |
MSFT Microsoft Corp
| 4.95% | $867.967M 2.345M shares@ $370.17 avg price | Increased 5.91% |
AON Aon Plc-class A
| 4.63% | $811.029M 2.513M shares@ $322.79 avg price | Decreased -5.72% |
BBIO Bridgebio Pharma Inc
| 3.97% | $695.479M 9.365M shares@ $74.26 avg price | Increased 4.08% |
ur-5⤦ Invesco Exchange Traded Fd T
| 3.94% | $690.912M↓ Put 3.6M shares@ $191.92 avg price | New Position |
PTGX Protagonist Therapeutics Inc
| 3.82% | $669.175M 6.349M shares@ $105.4 avg price | Increased 3.34% |
NTRA Natera Inc
| 3.66% | $641.441M 3.207M shares@ $199.99 avg price | Decreased -18.06% |
EXEL Exelixis Inc
| 3.21% | $562.331M 13.111M shares@ $42.9 avg price | Decreased -16.54% |
1-10 of 172